These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 25075795)
1. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors. Wang YY; Lv YF; Lu L; Cai L Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795 [TBL] [Abstract][Full Text] [Related]
2. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. Jiang JH; Pi J; Jin H; Cai JY J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997 [TBL] [Abstract][Full Text] [Related]
3. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
4. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects. Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686 [TBL] [Abstract][Full Text] [Related]
5. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells. Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852 [TBL] [Abstract][Full Text] [Related]
6. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells. Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways. Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741 [TBL] [Abstract][Full Text] [Related]
8. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway. Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993 [TBL] [Abstract][Full Text] [Related]
9. Oridonin Enhances Radiation-Induced Cell Death by Promoting DNA Damage in Non-Small Cell Lung Cancer Cells. Park H; Jeong YJ; Han NK; Kim JS; Lee HJ Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104472 [TBL] [Abstract][Full Text] [Related]
10. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells. Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515 [TBL] [Abstract][Full Text] [Related]
11. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells. Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253 [TBL] [Abstract][Full Text] [Related]
12. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway. Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103 [TBL] [Abstract][Full Text] [Related]
13. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751 [TBL] [Abstract][Full Text] [Related]
14. [Empirical study of oridonin-induced gastric cancer cells MKN45 apoptosis]. He XJ; Wang HJ; Xia YJ; Ye ZY; Tao HQ Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):607-10. PubMed ID: 19921575 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells. Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522 [TBL] [Abstract][Full Text] [Related]
16. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling. Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661 [TBL] [Abstract][Full Text] [Related]
17. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo. Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862 [TBL] [Abstract][Full Text] [Related]
19. Oridonin inhibits tumor growth in glioma by inducing cell cycle arrest and apoptosis. Zhang XH; Liu YX; Jia M; Han JS; Zhao M; Ji SP; Li AM Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):29-36. PubMed ID: 25553351 [TBL] [Abstract][Full Text] [Related]
20. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]